8 August 2026 in European Journal of Ophthalmology
Background: Early detection of diabetic retinopathy (DR) is crucial for preventing blindness. Optical coherence tomography angiography (OCTA) offers a non-invasive method for visualizing retinal microvasculature and may facilitate earlier detection of DR. This systematic review evaluates the current evidence regarding OCTA-derived biomarkers for the identification of early DR. Methods: A systematic review of the literature was performed. Due to substantial heterogeneity in study designs, OCTA protocols, and outcome measures, a meta-analysis was not feasible. Results: Twenty-one studies were included. OCTA scan sizes ranged from 3 × 3 mm to 6 × 6 mm and evaluated both the superficial and deep capillary plexuses. Vessel density (VD) was the most consistently reported biomarker, with reduced VD observed in early DR in 13 of 15 studies. Enlargement of the foveal avascular zone (FAZ) was reported in 9 of 17 studies. Microaneurysms were more frequently identified in diabetic eyes in 3 of 5 studies, while increased vessel tortuosity was reported in 2 of 5 studies. Discussion: Current evidence suggests that OCTA can detect retinal microvascular abnormalities associated with early DR before advanced clinical manifestations become evident. Reduced VD emerged as the most consistent indicator of early disease, while an increased microaneurysm burden may serve as a complementary marker. In contrast, the diagnostic value of FAZ alterations remains uncertain. Conclusion: By identifying the OCTA parameters most strongly associated with early DR, this review suggests the potential role of OCTA in earlier diagnosis, risk stratification, and monitoring of diabetic patients.
1 January 2024 in International Journal of Vascular Medicine
Introduction: The progression of aneurysmal disease in the common iliac arteries (CIAs) after EVAR remains an insufficiently investigated field. The purpose of this study is to investigate the long‐term outcomes of standard elective EVAR with a variety of last‐generation bifurcated aortic endografts in relation with the progression of aneurysmal disease in the CIAs.Methods: This is a prospective cohort study of 168 patients, who were treated with six different endografts between 2013 and 2018 and completed the 5‐year computed tomography aortoangiography (CTA) follow‐up. Postoperative CTA analysis included CIA measurements at four diameters’ points and two length levels in three postoperative time spots: first, 24th, and 60th months. All EVAR‐related adverse events were recorded, including migrations, endoleaks, limb occlusions, reinterventions, ruptures, and mortality.Results: At both time intervals, a significant and nearly linear dilatation and elongation of CIAs was evident. The mean percent increase, among all diameter points measured, was 11.7% at 24 months and 22.8% at 60 months (p < 0.001) with a nearly constant mean increase rate by 0.07 mm per month. The corresponding monthly elongation rate of total CIA length was 0.26 mm at 24 months and 0.34 mm at 5 years (p < 0.001). The respective monthly lengthening of CIAs’ uncovered (from stent graft) segment was 0.10 and 0.15 mm, and the overall increase rate at 60 months was up to 53.9% (p < 0.001). A total of 20 EVAR‐related events were recorded, and multivariate analysis revealed that CIA dilatation served as a significant and independent predictor of long‐term EVAR failures, increasing the likelihood of adverse events by 2.8‐fold.Conclusions: Analysis of long‐term geometric CIA remodeling after a standard EVAR revealed a significant progression of aneurysmal disease in CIAs, which was associated with worsening EVAR outcomes and emphasizes the importance of a rigorous and extensive follow‐up protocol to maintain the long‐term EVAR effectiveness.